Pediatrics

An Existing Drug May Have Therapeutic Potential in Mitochondrial Disease



Newswise imageNew preclinical findings from extensive cell and animal studies suggest that cysteamine bitartrate, a drug already used for a rare kidney disease, could benefit patients with some mitochondrial disorders. No proven effective treatments yet exist for these complex conditions with severe energy deficiency

Source link

Related posts

Few Mandatory Pediatric Postmarketing Studies Completed

Newsemia

For children born with HIV, adhering to medication gets harder with age

Newsemia

Infants' advances in speech processing play role in language-cognition link

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy